What is the price-to-earnings ratio of Benitec Biopharma?
The price-earnings ratio of Benitec Biopharma is currently -0.07.
Benitec Biopharma P/E 2024
Benitec Biopharma P/E
-0.07
Ticker
BNTC
ISIN
US08205P1003
WKN
722783
As of Aug 28, 2024, Benitec Biopharma's P/E ratio was -0.07, a -76.67% change from the -0.3 P/E ratio recorded in the previous year.
The Benitec Biopharma P/E history
Benitec Biopharma Aktienanalyse
What does Benitec Biopharma do?
Benitec Biopharma Inc is a biopharmaceutical company based in the United States that focuses on developing groundbreaking therapies for the treatment of serious diseases. The company was founded in 1995 and is headquartered in Hayward, California. Benitec Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Benitec Biopharma's P/E Ratio
The Price to Earnings (P/E) Ratio of Benitec Biopharma is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Benitec Biopharma's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Benitec Biopharma is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Benitec Biopharma’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Benitec Biopharma stock
How has the price-earnings ratio of Benitec Biopharma changed compared to last year?
The price-to-earnings ratio of Benitec Biopharma has increased by -76.67% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Benitec Biopharma high compared to other companies?
Yes, the price-to-earnings ratio of Benitec Biopharma is high compared to other companies.
How does an increase in the price-earnings ratio of Benitec Biopharma affect the company?
An increase in the price-earnings ratio of Benitec Biopharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Benitec Biopharma affect the company?
A decrease in the price-earnings ratio of Benitec Biopharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Benitec Biopharma?
Some factors that influence the price-earnings ratio of Benitec Biopharma are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Benitec Biopharma pay?
Over the past 12 months, Benitec Biopharma paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.47 %. For the coming 12 months, Benitec Biopharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Benitec Biopharma?
The current dividend yield of Benitec Biopharma is 0.47 %.
When does Benitec Biopharma pay dividends?
Benitec Biopharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Benitec Biopharma?
Benitec Biopharma paid dividends every year for the past 0 years.
What is the dividend of Benitec Biopharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Benitec Biopharma located?
Benitec Biopharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Benitec Biopharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Benitec Biopharma from 6/8/2018 amounting to 0.003 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2018.
When did Benitec Biopharma pay the last dividend?
The last dividend was paid out on 6/8/2018.
What was the dividend of Benitec Biopharma in the year 2023?
In the year 2023, Benitec Biopharma distributed 0 USD as dividends.
In which currency does Benitec Biopharma pay out the dividend?
The dividends of Benitec Biopharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Benitec Biopharma
Our stock analysis for Benitec Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Benitec Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Benitec Biopharma Revenue
- Benitec Biopharma Net Income
- Benitec Biopharma P/E
- Benitec Biopharma P/S
- Benitec Biopharma EBIT
- Benitec Biopharma Dividend
- Benitec Biopharma Stocks
- Benitec Biopharma Market capitalization
- Benitec Biopharma Debt
- Benitec Biopharma Liabilities
- Benitec Biopharma Equity
- Benitec Biopharma AAQS
- Benitec Biopharma Employees
- Benitec Biopharma ROE
- Benitec Biopharma ROA
- Benitec Biopharma ROCE
